Tidal Investments LLC reduced its position in Organigram Holdings Inc. (NASDAQ:OGI - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,723,004 shares of the company's stock after selling 225,184 shares during the period. Tidal Investments LLC owned 1.37% of Organigram worth $2,774,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Arrowstreet Capital Limited Partnership bought a new position in shares of Organigram in the 4th quarter worth $1,153,000. Dimensional Fund Advisors LP lifted its holdings in shares of Organigram by 13.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company's stock valued at $579,000 after purchasing an additional 43,721 shares in the last quarter. Oxford Asset Management LLP bought a new stake in shares of Organigram in the fourth quarter valued at about $50,000. Cubist Systematic Strategies LLC increased its position in shares of Organigram by 210.7% in the fourth quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock valued at $73,000 after acquiring an additional 30,583 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in shares of Organigram by 2.4% in the fourth quarter. Renaissance Technologies LLC now owns 914,648 shares of the company's stock valued at $1,473,000 after acquiring an additional 21,200 shares during the last quarter. 34.63% of the stock is owned by institutional investors and hedge funds.
Organigram Price Performance
NASDAQ OGI traded down $0.03 during trading on Tuesday, reaching $1.35. 216,529 shares of the company's stock were exchanged, compared to its average volume of 669,385. The business has a 50 day moving average price of $1.11 and a 200-day moving average price of $1.33. The stock has a market capitalization of $180.01 million, a P/E ratio of -3.54 and a beta of 1.35. Organigram Holdings Inc. has a fifty-two week low of $0.85 and a fifty-two week high of $2.08.
About Organigram
(
Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Featured Articles
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
